People · Operator
Named in public records as an officer, director or promoter · active 2012–2013 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mayne Pharma Group Ltd | — | Pharmaceuticals | Seed | $2.8M | $5.4M | 2012 |
Ian Scholes at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ian Scholes on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Scott Richards | 1 | 2 |
| Leigh Willis | 1 | 1 |
| Stefan Cross | 1 | 1 |
| Roger Corbett | 1 | 1 |
| Peter Truelove | 1 | 1 |
| Stefan Lukas | 1 | 1 |
| Richard Moldin | 1 | 1 |
| Ron Best | 1 | 1 |
| Brenton Walter | 1 | 1 |
| Mark Cansdale | 1 | 1 |
| Stuart Mudge | 1 | 1 |
| Bruce Mathieson | 1 | 1 |
| Phil Hodges | 1 | 1 |
| Vince Caretti | 1 | 1 |
| Phillip Tindall | 1 | 1 |
| Christelle Simpson | 1 | 1 |
| Andrew Dunbar | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.